| Dr Kristin C Sokol, MD | |
|
9601 Blackwell Rd Ste 275, Rockville, MD 20850-6492 | |
| (301) 545-5512 | |
| (301) 979-9090 |
| Full Name | Dr Kristin C Sokol |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 15 Years |
| Location | 9601 Blackwell Rd Ste 275, Rockville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982903498 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Schreiber Allergy | 4082934955 | 5 |
News Archive
A study performed at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus.
Artemisinin combination therapies (ACTs) could be almost as effective in reducing transmission of malaria as insecticide-treated bednets (ITNs) in areas of low transmission, a study based on data from Tanzania has found. In high transmission areas, long-acting antimalarial regimens may be needed to achieve significant transmission reductions.
Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, but are often symptom-free.
Infections with one of the most troublesome and least understood antibiotic-resistant "superbugs" are increasing at alarming rates, particularly in health-care settings.
Targeting apolipoprotein B gene has not been tested in clinical trials for cardiovascular outcomes because of risk of fatty liver disease, but naturally-occurring mutation suggests it may be effective.
› Verified 8 days ago
| Entity Name | Schreiber Allergy |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689066219 PECOS PAC ID: 4082934955 Enrollment ID: O20150515000707 |
News Archive
A study performed at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus.
Artemisinin combination therapies (ACTs) could be almost as effective in reducing transmission of malaria as insecticide-treated bednets (ITNs) in areas of low transmission, a study based on data from Tanzania has found. In high transmission areas, long-acting antimalarial regimens may be needed to achieve significant transmission reductions.
Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, but are often symptom-free.
Infections with one of the most troublesome and least understood antibiotic-resistant "superbugs" are increasing at alarming rates, particularly in health-care settings.
Targeting apolipoprotein B gene has not been tested in clinical trials for cardiovascular outcomes because of risk of fatty liver disease, but naturally-occurring mutation suggests it may be effective.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristin C Sokol, MD 9601 Blackwell Rd Ste 275, Rockville, MD 20850-6492 Ph: (301) 545-5512 | Dr Kristin C Sokol, MD 9601 Blackwell Rd Ste 275, Rockville, MD 20850-6492 Ph: (301) 545-5512 |
News Archive
A study performed at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus.
Artemisinin combination therapies (ACTs) could be almost as effective in reducing transmission of malaria as insecticide-treated bednets (ITNs) in areas of low transmission, a study based on data from Tanzania has found. In high transmission areas, long-acting antimalarial regimens may be needed to achieve significant transmission reductions.
Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, but are often symptom-free.
Infections with one of the most troublesome and least understood antibiotic-resistant "superbugs" are increasing at alarming rates, particularly in health-care settings.
Targeting apolipoprotein B gene has not been tested in clinical trials for cardiovascular outcomes because of risk of fatty liver disease, but naturally-occurring mutation suggests it may be effective.
› Verified 8 days ago
Dr. Ozge Nur Aktas, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 5601 Fishers Ln, Rockville, MD 20852 Phone: 866-600-2273 | |
Dr. Rachel Lise Schreiber, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9601 Blackwell Rd Ste 350, Rockville, MD 20850 Phone: 301-545-5512 Fax: 301-979-9090 | |
Dr. Yung-hao Howard Pung, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 11119 Rockville Pike, Suite 406, Rockville, MD 20852 Phone: 301-770-7756 Fax: 301-770-5870 | |
Shabnam Foroughi, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 10110 Molecular Dr, Suite 209, Rockville, MD 20850 Phone: 301-315-1500 Fax: 301-315-2545 | |
Dr. Paul Bernhard Keiser, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6000 Executive Blvd Ste 615, Rockville, MD 20852 Phone: 202-782-3321 | |
Dr. Julia Kim Sohn, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd Ste 100, Rockville, MD 20850 Phone: 301-869-7820 Fax: 301-762-2541 | |
Dr. Dennis Gary Kleban, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 19119 Rockville Pike, Rockville, MD 20852 Phone: 301-770-7007 |